ME Weinblatt, EC Keystone, DE Furst, LW … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 826 - Related articles - BL Direct - All 5 versions
- ►direct-ms.org [PDF] A Davidson, B Diamond - New England Journal of Medicine, 2001 - content.nejm.org Autoimmune diseases, with the exception of rheumatoid arthritis and autoimmune
thyroiditis, are individually rare, but together they affect approximately 5
percent of the population in Western countries. 1 , 2 They are a ... Cited by 447 - Related articles - All 13 versions
DE Furst, MH Schiff, RM Fleischmann, V … - J Rheumatol, 2003 - jrheum.org From the Division of Rheumatology, Department of Medicine, University of
California, Los Angeles, California, USA. Supported by Abbott Laboratories,
Abbott Park, Illinois, USA. DE Furst, MD, University of California; MH ... Cited by 262 - Related articles - All 14 versions
- ►nih.gov RK Amaravadi, D Yu, JJ Lum, T Bui, MA … - Journal of Clinical Investigation, 2007 - Am Soc Clin Investig Autophagy is a lysosome-dependent degradative pathway frequently activated in
tumor cells treated with chemotherapy or radiation. Whether autophagy observed
in treated cancer cells represents a mechanism that allows tumor cells to ... Cited by 113 - Related articles - BL Direct - All 9 versions
- ►kfshrc.edu.sa [PDF] DP Richman, MA Agius - Neurology, 2003 - AAN Enterprises Autoimmune myasthenia gravis (MG) is associated with antibodies directed against
the nicotinic acetylcholine receptor (AChR) in 85% of patients. Other
postsynaptic neuromuscular junction antigens are implicated, eg, ... Cited by 100 - Related articles - BL Direct - All 13 versions
R VELAGAPUDI, J KEMPENI, H KUPPER - The Journal of Rheumatology, 2002 - jrheum.org From the Department of Rheumatology, University Medical Center Nijmegen,
Nijmegen, The Netherlands; Department of Rheumatology, Evangelisches
Fachkrankenhaus, Ratingen, Germany; University of Munich, Munich, Germany; ... Cited by 95 - Related articles - All 8 versions
JB Wong, G Singh, A Kavanaugh - The American journal of medicine, 2002 - Elsevier We projected the 54-week results from a randomized controlled trial of
infliximab into lifetime economic and clinical outcomes using a Markov computer
simulation model. Direct and indirect costs, quality of life, and ... Cited by 88 - Related articles - All 10 versions
JR Curtis, N Patkar, A Xie, C Martin, JJ … - Arthritis Care & Research - interscience.wiley.com Dr. Michael Saag has received grants and/or research support (less than $10,000
each) from Achillion Pharmaceutica, Boehringer-Ingelheim, Gilead Sciences,
GlaxoSmithKline, Merck, Panacos, Pfizer/Agouron, Progenics, Roche, Serono, ... Cited by 72 - Related articles - BL Direct - All 5 versions
IK Nahar, K Shojania, CA Marra, AH Alamgir, … - The Annals of pharmacotherapy, 2003 - Harvey Whitney Books STUDY SELECTION/DATA EXTRACTION: All articles identified from data sources were
evaluated, and all information deemed relevant was included in this review.
Information regarding basic pharmacology was collected from studies in ... Cited by 69 - Related articles - BL Direct - All 5 versions
